302 related articles for article (PubMed ID: 15673313)
41. Analysis of risk factors for death in 59 cases of critically ill neonates receiving continuous renal replacement therapy: a two-centered retrospective study.
Xu J; Chu X; Zhang W; Sun Y; Qiu G; Cai C; Chen D
Eur J Pediatr; 2023 Jan; 182(1):353-361. PubMed ID: 36369399
[TBL] [Abstract][Full Text] [Related]
42. Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury.
Shum HP; Chan KC; Kwan MC; Yeung AW; Cheung EW; Yan WW
Ther Apher Dial; 2013 Jun; 17(3):305-10. PubMed ID: 23735146
[TBL] [Abstract][Full Text] [Related]
43. Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group.
Zappitelli M; Goldstein SL; Symons JM; Somers MJ; Baum MA; Brophy PD; Blowey D; Fortenberry JD; Chua AN; Flores FX; Benfield MR; Alexander SR; Askenazi D; Hackbarth R; Bunchman TE;
Crit Care Med; 2008 Dec; 36(12):3239-45. PubMed ID: 18936697
[TBL] [Abstract][Full Text] [Related]
44. Survival to discharge among patients treated with continuous renal replacement therapy.
Wald R; Deshpande R; Bell CM; Bargman JM
Hemodial Int; 2006 Jan; 10(1):82-7. PubMed ID: 16441832
[TBL] [Abstract][Full Text] [Related]
45. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
Brophy PD; Somers MJ; Baum MA; Symons JM; McAfee N; Fortenberry JD; Rogers K; Barnett J; Blowey D; Baker C; Bunchman TE; Goldstein SL
Nephrol Dial Transplant; 2005 Jul; 20(7):1416-21. PubMed ID: 15855212
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors in pediatric cancer patients admitted to the pediatric intensive care unit.
Dursun O; Hazar V; Karasu GT; Uygun V; Tosun O; Yesilipek A
J Pediatr Hematol Oncol; 2009 Jul; 31(7):481-4. PubMed ID: 19564740
[TBL] [Abstract][Full Text] [Related]
47. Predictors of mortality in a cohort of intensive care unit patients with acute renal failure receiving continuous renal replacement therapy.
Brar H; Olivier J; Lebrun C; Gabbard W; Fulop T; Schmidt D
Am J Med Sci; 2008 May; 335(5):342-7. PubMed ID: 18480649
[TBL] [Abstract][Full Text] [Related]
48. Clinical impact of continuous renal replacement therapy on multiple organ failure.
Dunham CM
World J Surg; 2001 May; 25(5):669-76. PubMed ID: 11396437
[TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of continuous renal replacement therapy for children less than 10 kg using standard adult machines.
Kedarnath M; Alexander EC; Deep A
Eur J Pediatr; 2023 Aug; 182(8):3619-3629. PubMed ID: 37233776
[TBL] [Abstract][Full Text] [Related]
50. [Continuous renal replacement therapy for severe acute renal failure].
Shao YH; Huang YW; Kong YZ; Zhou LX; Lin MW; Xiao GQ
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1388-90. PubMed ID: 15604065
[TBL] [Abstract][Full Text] [Related]
51. Metabolic disturbances following the use of inadequate solutions for hemofiltration in acute renal failure.
Soysal DD; Karaböcüoğlu M; Citak A; Uçsel R; Uzel N; Nayir A
Pediatr Nephrol; 2007 May; 22(5):715-9. PubMed ID: 17146668
[TBL] [Abstract][Full Text] [Related]
52. Does early initiation of continuous renal replacement therapy affect outcome: experience in a tertiary care center.
Vats HS; Dart RA; Okon TR; Liang H; Paganini EP
Ren Fail; 2011; 33(7):698-706. PubMed ID: 21787161
[TBL] [Abstract][Full Text] [Related]
53. Continuous renal replacement therapy for non-renal indications: experience in children.
Kornecki A; Tauman R; Lubetzky R; Sivan Y
Isr Med Assoc J; 2002 May; 4(5):345-8. PubMed ID: 12040822
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.
Cies JJ; Moore WS; Miller K; Small C; Carella D; Conley S; Parker J; Shea P; Chopra A
Pharmacotherapy; 2015 Feb; 35(2):229-33. PubMed ID: 25556960
[TBL] [Abstract][Full Text] [Related]
55. Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case-control study.
Cui Y; Shi J; Lu G; Wang Y; Zhu X; Ren H; Zhu Y; Yan G; Wang C; Zhang Y
Ther Apher Dial; 2022 Oct; 26(5):1023-1029. PubMed ID: 34877787
[TBL] [Abstract][Full Text] [Related]
56. Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy.
Betrus C; Remenapp R; Charpie J; Kudelka T; Brophy P; Smoyer WE; Lin JJ
Ann Thorac Cardiovasc Surg; 2007 Dec; 13(6):378-83. PubMed ID: 18292719
[TBL] [Abstract][Full Text] [Related]
57. [Effects of serum of patients with MODS on TF and PAI-1 secretion of human vascular endothelial cells during CRRT].
Wang JW; Peng YM; Liu FY; Zhang H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jun; 25(6):534-6. PubMed ID: 19500510
[TBL] [Abstract][Full Text] [Related]
58. The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: design, development and data assessed.
Goldstein SL; Somers MJ; Brophy PD; Bunchman TE; Baum M; Blowey D; Mahan JD; Flores FX; Fortenberry JD; Chua A; Alexander SR; Hackbarth R; Symons JM
Int J Artif Organs; 2004 Jan; 27(1):9-14. PubMed ID: 14984178
[TBL] [Abstract][Full Text] [Related]
59. Meropenem in children receiving continuous renal replacement therapy: clinical trial simulations using realistic covariates.
Nehus EJ; Mouksassi S; Vinks AA; Goldstein S
J Clin Pharmacol; 2014 Dec; 54(12):1421-8. PubMed ID: 25042683
[TBL] [Abstract][Full Text] [Related]
60. Continuous renal replacement therapy in children up to 10 kg.
Symons JM; Brophy PD; Gregory MJ; McAfee N; Somers MJ; Bunchman TE; Goldstein SL
Am J Kidney Dis; 2003 May; 41(5):984-9. PubMed ID: 12722032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
